Santen CEO joins Glaucoma Research Foundation
Adrienne Graves, CEO of Santen Inc., has been appointed to the Glaucoma Research Foundation?s board of directors.
Adrienne Graves, CEO of Santen Inc., has been appointed to the Glaucoma Research Foundation’s board of directors.
Prior to joining Santen in 1995, Graves worked with Alcon Labs having studied visual psychophysics and electrophysiology.
Having observed the quality of Dr Graves’ work as a scientist and CEO, I feel she brings tremendous energy, experience and qualifications to the board, said Dr Kuldev Singh, chair of the Glaucoma Research Foundation.
Graves co-founded Ophthalmic Women Leaders with Dr Marguerite McDonald and is on the boards of the American Academy of Ophthalmology Foundation, the Pan-American Ophthalmological Foundation and the corporation committee for the Brown University Medical School.
